Prevalence of gyrA , gyrB , parC , and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season
- 1 February 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (2) , 462-466
- https://doi.org/10.1128/aac.44.2.462-466.2000
Abstract
From 8,419 worldwide clinical isolates of Streptococcus pneumoniae obtained during 1997-1998, 69 isolates with reduced susceptibility or resistance to fluoroquinolones (FQs) were molecularly characterized. For the isolates in this prevalence study, only parC (Ser-79→Tyr) and gyrA (Ser-81→Phe or Tyr) mutations, especially in combination, were found to contribute significantly to resistance. These mutations influenced the FQ MICs to varying degrees, although the rank order of activity remains independent of mutation type, with ciprofloxacin the least active, followed by levofloxacin, gatifloxacin/grepafloxacin/moxifloxacin/sparfloxacin/trovafloxacin, and clinafloxacin/sitafloxacin. Efflux likely plays a crucial role in reduced susceptibility for new hydrophilic FQs.Keywords
This publication has 25 references indexed in Scilit:
- Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998Journal of Antimicrobial Chemotherapy, 2000
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- International Surveillance of Susceptibility to Levofloxacin and Other Agents among Respiratory PathogensDrugs, 1999
- Surveillance of Antimicrobial Resistance among Respiratory Tract Pathogens in the United States, 1997 to 1998Drugs, 1999
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- Epidemiology and management of penicillin-resistant pneumococciCurrent Opinion in Infectious Diseases, 1996
- Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University WorkshopNew England Journal of Medicine, 1994
- In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinoloneAntimicrobial Agents and Chemotherapy, 1992
- In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1992
- Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinoloneAntimicrobial Agents and Chemotherapy, 1991